spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  prostate specific antigen 

 HSMN NewsFeed - 25 Nov 2019
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2018
Trovagene Announces Exclusive License Agreement with MIT for Combination Therapy of Anti-Androgens and Polo-like Kinase Inhibitors in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 11 Oct 2017
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2017
IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology (ASTRO) Conference
Devices Oncology
 HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2014
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 May 2014
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2014
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 4 Jun 2013
First Head-to-Head Study Shows Greenlight XPS(R) Laser Therapy Equally Safe and Effective with Faster Recovery as Commonly Used Turp for Treatment of BPH
Devices Urology
 HSMN NewsFeed - 24 Jul 2012
Debiopharm Group(TM) - First Patient Treated in Phase III Study With Subcutaneous Administration of Debio 8206 for Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2012
FIRMAGON(R) (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in prostate cancer patients while providing better relief from lower urinary tract symptoms
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 8 Jun 2011
FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Mar 2010
AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals
 HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2008
Next Generation CyberKnife System Cuts Prostate Cancer Treatment Times in Half at CyberKnife Centers of San Diego
Devices Oncology
 HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Aureon Laboratories Introduces Prostate Px(R)+, First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence
Diagnostics Urology Oncology
 HSMN NewsFeed - 16 May 2008
LabCorp First Company to Commercially Launch Gene Methylation Test for Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 5 May 2008
Robotic Radiosurgery Course Yields Record Attendance
Devices Oncology
 HSMN NewsFeed - 8 Apr 2008
CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal
Devices Oncology
 HSMN NewsFeed - 27 Mar 2008
Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Mar 2008
New Study Backs use of Gene-Based Urine Test in Prostate Cancer
Diagnostics Oncology Urology
 HSMN NewsFeed - 27 Feb 2008
FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
Diagnostics FDA
 HSMN NewsFeed - 12 Feb 2008
CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends
Devices Oncology
 HSMN NewsFeed - 25 Jun 2007
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 31 May 2007
Panacea Pharmaceuticals Announces the Availability of PC Detect(sm) for Prostate Cancer Screening
Diagnostics Oncology
 HSMN NewsFeed - 29 May 2007
LabCorp(R) Licenses Gene Methylation Technology for Prostate Cancer from Veridex, LLC
Diagnostics Oncology Licensing
 HSMN NewsFeed - 30 Apr 2007
New Study Shows That Cesium-131 From IsoRay Medical(TM) Is an Effective, Well-Tolerated Brachytherapy Treatment for Prostate Cancer with Fewer Side Effects Than Other Medical Isotopes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Mar 2007
Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Mar 2007
Miraculins Announces Positive Results in Pivotal Prostate Cancer Biomarker Study
Diagnostics Oncology
 HSMN NewsFeed - 23 Feb 2007
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2007
Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2007
Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jan 2007
Immunicon Achieves Endpoint in its Pivotal Clinical Trial in Metastatic Androgen-Independent Prostate Cancer
Diagnostics Oncology
 HSMN NewsFeed - 8 Jan 2007
Myriad Genetics Announces Results of Phase 2 Prostate Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Nov 2006
Study Shows Ambrilia's PSP94 Immunoassay to Have Prognostic Value in Prostate Cancer Management
Biopharmaceuticals Diagnostics Oncology Urology
 HSMN NewsFeed - 1 Nov 2006
Cellgate Commences Phase II Clinical Trial of Anticancer Compound CGC-11047 for Prostate Cancer
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 58

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 58 additional stories matching:
prostate specific antigen
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!